Peptocid 87.5 mg/5 ml is a Product of the Generic Bismuth Subsalicylate

Peptocid 87.5 mg/5 ml | INDICATIONS AND USES

Bismuth Subsalicylate is indicated for-

Upset stomach
Indigestion
Heartburn
Nausea
Diarrhea.

Peptocid 87.5 mg/5 ml | PHARMACOLOGY

Antacid action: Bismuth Subsalicylate coats ulcer surface, protecting it from acid and pepsin. It stimulates mucus and bicarbonate secretion and also reacts with HCl, produces bismuth oxychloride and salicylic acid thus reduces HCl.Anti-diarrheal action: It stimulates absorption of water and electrolytes across the intestinal wall. In infectious diarrhea it binds with toxin produced by E.coli, disrupts cell, causing lysis of H.pylori and prevents adhesion of H.pylori in the cell wall of intestine.Anti-inflammatory action: When hydrolyzed to salicylic acid, it inhibits prostaglandin G/H synthase ½. Thus reduces inflammation and Coats the irritated tissue to retard the expulsion of fluid.

Peptocid 87.5 mg/5 ml | DOSAGE & ADMINISTRATION

Adult (>16): 30 ml in dosing cup provided or 6x5 ml spoonfulChildren (10-14 years): 15 mL (3 teaspoons)Children (5-9 years): 7.5 mL (1.5 teaspoons)Children (3-4 years): 5 mL (1 teaspoon)Children under 3 years: Ask a doctor.Use in the elderly: No special precaution is needed. Patient is suffering from renal insufficiency: caution should be taken.Repeat dose every ½ to 1 hour if needed. Not more than 8 doses to be taken in 24 hours.

Peptocid 87.5 mg/5 ml | DRUG INTERACTIONS

Bismuth Subsalicylate Contains salicylates therefore care should be exercised if receiving drugs to thin the blood (anticoagulant therapy) or oral therapy for diabetes or treatment for gout or arthritis.

Peptocid 87.5 mg/5 ml | SIDE EFFECTS

Black stool and black tongue is common with use of Bismuth Subsalicylate. Bismuth Subsalicylate should not be used if symptoms are severe or persist for more than 2 days. Do not exceed the recommended dose, shake the bottle before use. For oral use only.

Peptocid 87.5 mg/5 ml | USE DURING PREGNANCY AND LACTATION

There are no adequate data concerning the use of Bismuth Subsalicylate in pregnant women. Animal studies are insufficient with respect to effects on pregnancy, embryonal/foetal development, parturition and postnatal development. The potential risk for humans is unknown. Bismuth Subsalicylate should not be used during lactation unless clearly necessary.

Peptocid 87.5 mg/5 ml | PRECAUTIONS & WARNINGS

Do not take with aspirin or other salicylates. Caution should be exercised by patients taking medicines for anti-coagulation (thinning of the blood), diabetes or gout.

Peptocid 87.5 mg/5 ml | STORAGE CONDITIONS

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.